The Filings Report

Royalty Pharma plc Class A Ordinary Shares insider trading

RPRXfinancial statementsForm 4 filings on EDGAR140 transactions since Nov 1, 2024

From August 4, 2026 to November 1, 2026, 0 insiders at Royalty Pharma plc Class A Ordinary Shares bought $0 of stock in the open market, and 3 sold $13M. Officers and directors accounted for $0 of purchases and $13M of sales. The last reported transaction was an open-market sale by Urist Marshall on October 5, 2026.

The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 5, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.

Stock price and insider activity

Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.

RPRX daily priceSplit-adjusted prices in US dollars

Bought $0Sold $13MAug 4, 2026 – Nov 1, 2026

Oct 30, 2026O $67.00 · H $67.71 · L $66.40 · C $67.18Bought $0 (0)Sold $0 (0)
$54$58$61$65$682026-08-04: open $57.17, high $58.04, low $56.36, close $57.482026-08-05: open $59.53, high $59.63, low $57.41, close $57.752026-08-06: open $58.94, high $59.19, low $56.83, close $57.262026-08-07: open $57.44, high $57.66, low $56.60, close $56.772026-08-10: open $57.43, high $58.03, low $56.53, close $57.972026-08-11: open $58.04, high $58.63, low $57.76, close $57.792026-08-12: open $57.75, high $59.33, low $57.65, close $59.222026-08-13: open $59.50, high $59.58, low $57.95, close $58.562026-08-14: open $57.89, high $58.78, low $57.72, close $58.602026-08-17: open $58.36, high $59.49, low $58.18, close $59.452026-08-18: open $59.74, high $60.42, low $59.66, close $59.692026-08-19: open $60.12, high $61.80, low $59.75, close $61.732026-08-20: open $61.33, high $62.13, low $60.37, close $60.582026-08-21: open $60.53, high $61.60, low $60.37, close $61.312026-08-24: open $61.19, high $61.54, low $60.80, close $61.332026-08-25: open $61.33, high $62.46, low $60.87, close $62.072026-08-26: open $62.04, high $62.28, low $61.49, close $61.802026-08-27: open $61.42, high $62.35, low $61.01, close $61.922026-08-28: open $61.92, high $62.01, low $60.66, close $60.852026-08-31: open $60.81, high $61.68, low $60.39, close $61.412026-09-01: open $61.82, high $62.58, low $61.61, close $62.322026-09-02: open $62.66, high $63.29, low $62.03, close $63.112026-09-03: open $63.57, high $63.94, low $62.50, close $63.882026-09-04: open $63.55, high $64.38, low $63.43, close $63.962026-09-08: open $59.21, high $60.86, low $58.63, close $60.592026-09-09: open $60.60, high $60.80, low $59.31, close $60.592026-09-10: open $60.45, high $60.71, low $58.64, close $58.752026-09-11: open $58.95, high $59.54, low $58.35, close $58.612026-09-14: open $58.66, high $59.55, low $57.75, close $59.052026-09-15: open $59.00, high $59.20, low $57.91, close $58.472026-09-16: open $59.00, high $59.17, low $58.27, close $58.472026-09-17: open $58.81, high $59.18, low $58.46, close $58.932026-09-18: open $58.63, high $58.96, low $57.97, close $58.412026-09-21: open $58.56, high $59.07, low $57.82, close $58.442026-09-22: open $58.27, high $59.03, low $57.86, close $58.522026-09-23: open $58.52, high $59.02, low $57.63, close $57.652026-09-24: open $57.69, high $58.87, low $57.66, close $58.292026-09-25: open $58.50, high $58.50, low $57.68, close $58.212026-09-28: open $57.88, high $58.77, low $57.63, close $58.372026-09-29: open $58.19, high $58.48, low $57.51, close $58.222026-09-30: open $58.07, high $58.64, low $57.70, close $58.362026-10-01: open $58.36, high $58.40, low $57.22, close $57.632026-10-02: open $57.64, high $57.91, low $56.96, close $57.162026-10-05: open $57.10, high $57.25, low $56.01, close $56.662026-10-06: open $56.66, high $57.13, low $56.04, close $56.442026-10-07: open $56.61, high $57.16, low $56.41, close $56.762026-10-08: open $56.57, high $56.71, low $55.13, close $56.212026-10-09: open $56.03, high $57.08, low $55.72, close $56.932026-10-12: open $57.04, high $57.92, low $56.85, close $57.782026-10-13: open $57.70, high $57.97, low $56.42, close $56.572026-10-14: open $56.93, high $59.08, low $56.78, close $58.992026-10-15: open $59.75, high $60.41, low $59.50, close $59.622026-10-16: open $59.89, high $61.31, low $59.72, close $60.962026-10-19: open $60.54, high $61.12, low $60.04, close $60.272026-10-20: open $60.92, high $62.42, low $60.78, close $62.252026-10-21: open $62.10, high $62.90, low $62.00, close $62.152026-10-22: open $62.34, high $63.84, low $62.34, close $63.752026-10-23: open $63.50, high $63.97, low $63.01, close $63.862026-10-26: open $64.06, high $65.35, low $64.06, close $64.762026-10-27: open $64.71, high $65.51, low $64.45, close $65.282026-10-28: open $64.82, high $65.34, low $63.49, close $64.822026-10-29: open $65.34, high $66.29, low $64.93, close $65.932026-10-30: open $67.00, high $67.71, low $66.40, close $67.18Insider purchases / sales · USD$10M$0−$10M2026-08-13: 0 purchases ($0), 2 sales ($646K)2026-08-18: 0 purchases ($0), 1 sales ($6M)2026-09-22: 0 purchases ($0), 2 sales ($6M)2026-09-28: 0 purchases ($0), 1 sales ($239K)2026-10-05: 0 purchases ($0), 1 sales ($236K)Aug 4Aug 26Sep 17Oct 9Oct 30

purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.

Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.

Every transaction

140 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 5, 2026Urist MarshallEVP, Research & Investmentsopen-market sale10b5-14,126$57.10$236K0Oct 5, 2026
Sep 30, 2026Bassler Bonnie LDirectoraward642$58.41$37K79,823Sep 30, 2026
Sep 28, 2026Urist MarshallEVP, Research & Investmentsopen-market sale10b5-14,126$57.88$239K4,126Sep 30, 2026
Sep 22, 2026Hite ChristopherEVP & Chairman, Partneringopen-market sale10b5-1indirect96,073$58.51$6M274,328Sep 24, 2026
Sep 22, 2026Hite ChristopherEVP & Chairman, Partneringopen-market sale10b5-1indirect3,927$58.93$231K270,401Sep 24, 2026
Aug 19, 2026Hite ChristopherEVP & Chairman, Partneringgift16,800$0.00—23,200Aug 19, 2026
Aug 18, 2026Hite ChristopherEVP & Chairman, Partneringopen-market sale10b5-1indirect100,000$59.97$6M370,401Aug 19, 2026
Aug 13, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect9,230$58.59$541K1,772Aug 17, 2026
Aug 13, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect1,772$59.14$105K0Aug 17, 2026
Aug 5, 2026Legorreta Pablo G.CEO, Chairman of the Board, Directoraward65,216$0.00—1MAug 7, 2026
Aug 5, 2026Coyne Terrance P.EVP & CFOawardindirect11,002$0.00—11,002Aug 7, 2026
Aug 5, 2026Hite ChristopherEVP & Chairman, Partneringawardindirect11,002$0.00—470,401Aug 7, 2026
Aug 5, 2026Urist MarshallEVP, Research & Investmentsaward8,252$0.00—8,252Aug 7, 2026
Jul 1, 2026Urist MarshallEVP, Research & Investmentsopen-market sale10b5-19,099$55.88$508K0Jul 2, 2026
Jun 30, 2026Hite ChristopherEVP & Chairman, Partneringopen-market sale10b5-1indirect97,446$56.50$6M461,953Jul 2, 2026
Jun 30, 2026Hite ChristopherEVP & Chairman, Partneringopen-market sale10b5-1indirect2,554$57.10$146K459,399Jul 2, 2026
Jun 30, 2026Hite ChristopherEVP & Chairman, Partneringopen-market sale10b5-129,400$56.44$2M40,600Jul 2, 2026
Jun 30, 2026Hite ChristopherEVP & Chairman, Partneringopen-market sale10b5-1600$57.09$34K40,000Jul 2, 2026
Jun 30, 2026Bassler Bonnie LDirectoraward689$54.40$37K79,181Jun 30, 2026
Jun 24, 2026Urist MarshallEVP, Research & Investmentsopen-market sale10b5-19,098$55.18$502K9,099Jun 25, 2026
Jun 23, 2026Hite ChristopherEVP & Chairman, Partneringopen-market sale10b5-1indirect32,408$54.11$2M676,991Jun 25, 2026
Jun 23, 2026Hite ChristopherEVP & Chairman, Partneringopen-market sale10b5-1indirect117,592$54.47$6M559,399Jun 25, 2026
Jun 5, 2026Weatherman Elizabeth HDirectoraward4,545$0.00—13,103Jun 8, 2026
Jun 5, 2026Norden GregoryDirectoraward4,545$0.00—196,348Jun 8, 2026
Jun 5, 2026Love Ted WDirectoraward4,545$0.00—58,393Jun 8, 2026
Jun 5, 2026Hodgson David CDirectoraward4,545$0.00—37,873Jun 8, 2026
Jun 5, 2026Ho CaroleDirectoraward4,545$0.00—4,545Jun 8, 2026
Jun 5, 2026Engelbert Catherine M.Directoraward4,545$0.00—55,673Jun 8, 2026
Jun 5, 2026Coric VladDirectoraward4,545$0.00—15,343Jun 8, 2026
Jun 5, 2026Bassler Bonnie LDirectoraward4,545$0.00—78,492Jun 8, 2026
May 26, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect64,399$53.98$3M0May 28, 2026
May 20, 2026Urist MarshallEVP, Research & Investmentsopen-market sale10b5-113,684$52.75$722K18,197May 21, 2026
May 14, 2026Urist MarshallEVP, Research & Investmentsopen-market sale10b5-113,684$53.06$726K31,881May 15, 2026
May 14, 2026Norden GregoryDirectoropen-market sale10b5-13,045$53.00$161K191,803May 15, 2026
May 6, 2026Legorreta Pablo G.CEO, Chairman of the Board, Directoraward143,821$0.00—1MMay 8, 2026
May 6, 2026Coyne Terrance P.EVP & CFOawardindirect24,263$0.00—64,399May 8, 2026
May 6, 2026Hite ChristopherEVP & Vice Chairmanawardindirect24,263$0.00—709,399May 8, 2026
May 6, 2026Urist MarshallEVP, Research & Investmentsaward18,197$0.00—45,565May 8, 2026
Apr 28, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect32,916$49.78$2M0Apr 30, 2026
Apr 28, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect1,875$49.78$93K40,136Apr 30, 2026
Apr 1, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect1,875$48.33$91K42,011Apr 2, 2026
Apr 1, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect32,916$48.33$2M32,916Apr 2, 2026
Mar 31, 2026Bassler Bonnie LDirectoraward815$45.98$37K73,947Mar 31, 2026
Mar 31, 2026Bassler Bonnie LDirectoraward815$45.98$37K73,947Mar 31, 2026
Mar 23, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect32,916$45.53$1M65,832Mar 25, 2026
Mar 23, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect1,875$45.53$85K43,886Mar 25, 2026
Mar 2, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect1,292$46.67$60K46,344Mar 4, 2026
Mar 2, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect10,429$47.01$490K98,748Mar 4, 2026
Mar 2, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect22,487$46.67$1M109,177Mar 4, 2026
Mar 2, 2026Coyne Terrance P.EVP & CFOopen-market sale10b5-1indirect583$47.01$27K45,761Mar 4, 2026

Who the insiders are

Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.

InsiderRoleLast transactionKindShares heldBought, 12 monthsSold, 12 monthsSales under a plan
Coyne Terrance P.EVP & CFOAug 13, 2026open-market sale——$39M (35)35 of 35
Hite ChristopherEVP & Chairman, PartneringSep 22, 2026open-market sale23,200—$27M (9)9 of 9
Lloyd George W.EVP, Investments & CLODec 18, 2025open-market sale0—$14M (11)11 of 11
Urist MarshallEVP, Research & InvestmentsOct 5, 2026open-market sale0—$13M (18)18 of 18
Norden GregoryDirectorJun 5, 2026award196,348—$161K (1)1 of 1
Bassler Bonnie LDirectorSep 30, 2026award79,823———
Legorreta Pablo G.CEO, Chairman of the Board, DirectorAug 5, 2026award1M———
Fernandez Henry ADirectorJun 30, 2025award65,324———
Weatherman Elizabeth HDirectorJun 5, 2026award13,103———
Ho CaroleDirectorJun 5, 2026award4,545———
Coric VladDirectorJun 5, 2026award15,343———
Love Ted WDirectorJun 5, 2026award58,393———
Hodgson David CDirectorJun 5, 2026award37,873———
Engelbert Catherine M.DirectorJun 5, 2026award55,673———
Desouza Errol BDirectorMay 13, 2025award81,352———

Questions

Are Royalty Pharma plc Class A Ordinary Shares insiders buying or selling?

Over the twelve months to November 1, 2026, 5 insiders at Royalty Pharma plc Class A Ordinary Shares sold $93M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $93M. Only open-market purchases and sales are counted.

Who sold the most Royalty Pharma plc Class A Ordinary Shares stock in the last year?

Coyne Terrance P. (EVP & CFO) sold $39M in 35 open-market sales over the twelve months to November 1, 2026.

Do Royalty Pharma plc Class A Ordinary Shares executives sell under 10b5-1 plans?

74 of the 74 open-market sales in the last twelve months (100%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.

What counts as insider buying here?

Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.

More on Royalty Pharma plc Class A Ordinary Shares

From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.